Merck & Co., Inc. (MRK) Marketable Securities, Current USD 2010 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of investment in marketable security, classified as current.
Summary
Merck & Co., Inc. quarterly Marketable Securities, Current history and growth rate from 2010 to 2024.
  • Merck & Co., Inc. Marketable Securities, Current for the quarter ending March 31, 2024 was $40M.
Marketable Securities, Current, Quarterly Data (USD)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $40M Mar 31, 2024 10-Q 2024-05-03
Q4 2023 $252M -$246M -49.4% Dec 31, 2023 10-Q 2024-05-03
Q3 2023 $168M Sep 30, 2023 10-Q 2023-11-03
Q4 2022 $498M Dec 31, 2022 10-K 2024-02-26
Q4 2020 $0 -$774M -100% Dec 31, 2020 10-K 2021-02-25
Q3 2020 $0 -$149M -100% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $0 -$446M -100% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 $7M -$715M -99% Mar 31, 2020 10-Q 2020-05-06
Q4 2019 $774M -$125M -13.9% Dec 31, 2019 10-K 2021-02-25
Q3 2019 $149M -$2.31B -93.9% Sep 30, 2019 10-Q 2019-11-05
Q2 2019 $446M -$1.84B -80.5% Jun 30, 2019 10-Q 2019-08-06
Q1 2019 $722M -$2.14B -74.8% Mar 31, 2019 10-Q 2019-05-08
Q4 2018 $899M -$1.51B -62.6% Dec 31, 2018 10-K 2020-02-26
Q3 2018 $2.46B -$835M -25.3% Sep 30, 2018 10-Q 2018-11-06
Q2 2018 $2.28B -$1.9B -45.4% Jun 30, 2018 10-Q 2018-08-07
Q1 2018 $2.86B -$678M -19.1% Mar 31, 2018 10-Q 2018-05-08
Q4 2017 $2.41B -$5.42B -69.3% Dec 31, 2017 10-K 2019-02-27
Q3 2017 $3.29B -$1.87B -36.2% Sep 30, 2017 10-Q 2017-11-07
Q2 2017 $4.18B -$1.05B -20% Jun 30, 2017 10-Q 2017-08-08
Q1 2017 $3.54B +$314M +9.73% Mar 31, 2017 10-Q 2017-05-09
Q4 2016 $7.83B +$2.92B +59.6% Dec 31, 2016 10-K 2018-02-27
Q3 2016 $5.16B +$619M +13.6% Sep 30, 2016 10-Q 2016-11-07
Q2 2016 $5.23B +$778M +17.5% Jun 30, 2016 10-Q 2016-08-08
Q1 2016 $3.23B -$4.39B -57.7% Mar 31, 2016 10-Q 2016-05-09
Q4 2015 $4.9B -$3.38B -40.8% Dec 31, 2015 10-K 2017-02-28
Q3 2015 $4.54B +$1.56B +52.5% Sep 30, 2015 10-Q 2015-11-05
Q2 2015 $4.45B +$796M +21.8% Jun 30, 2015 10-Q 2015-08-06
Q1 2015 $7.62B +$2.94B +62.7% Mar 31, 2015 10-Q 2015-05-07
Q4 2014 $8.28B +$6.41B +344% Dec 31, 2014 10-K 2016-02-26
Q3 2014 $2.98B -$1.1B -27% Sep 30, 2014 10-Q 2014-11-10
Q2 2014 $3.65B +$644M +21.4% Jun 30, 2014 10-Q 2014-08-07
Q1 2014 $4.69B +$1.69B +56.3% Mar 31, 2014 10-Q 2014-05-08
Q4 2013 $1.87B -$825M -30.7% Dec 31, 2013 10-K 2015-02-27
Q3 2013 $4.08B +$3.32B +439% Sep 30, 2013 10-Q 2013-11-07
Q2 2013 $3.01B +$2.31B +331% Jun 30, 2013 10-Q 2013-08-07
Q1 2013 $3B +$2.09B +229% Mar 31, 2013 10-Q 2013-05-09
Q4 2012 $2.69B +$1.25B +86.7% Dec 31, 2012 10-K 2014-02-27
Q3 2012 $757M -$566M -42.8% Sep 30, 2012 10-Q 2012-11-09
Q2 2012 $698M -$941M -57.4% Jun 30, 2012 10-Q 2012-08-07
Q1 2012 $910M -$424M -31.8% Mar 31, 2012 10-Q 2012-05-08
Q4 2011 $1.44B +$140M +10.8% Dec 31, 2011 10-K 2013-02-28
Q3 2011 $1.32B +$573M +76.3% Sep 30, 2011 10-Q 2011-11-08
Q2 2011 $1.64B +$362M +28.3% Jun 30, 2011 10-Q 2011-08-08
Q1 2011 $1.33B -$207M -13.5% Mar 31, 2011 10-Q 2011-05-09
Q4 2010 $1.3B Dec 31, 2010 10-K 2012-02-28
Q3 2010 $750M Sep 30, 2010 10-Q 2010-11-08
Q2 2010 $1.28B Jun 30, 2010 10-Q 2010-08-06
Q1 2010 $1.54B Mar 31, 2010 10-Q 2010-05-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.